Biostime International Holdings A$1.67 billion acquisition of Swisse Wellness Group

17/9/2015

Private acquisition

Value:

Af 1.67 billion

Dollar value:

$ 1.32 billion

Status:

Announced

Date:

17/9/2015

Overview:

Biostime International Holdings has acquired 83% of Swisse Wellness Group for A$1.67 billion.
Biostime is a Chinese health food manufacturer.
Swisse Wellness is an Australian vitamin and supplement manufacturer.
Biostime funded the deal using a bridge loan.
Swisse's former controlling shareholders have maintained a minority interest in the business.

Katrin Kostadinova - Data analyst

Jurisdiction:

Australia

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

Australia

Industry sector:

Consumer goods and services

Firms:

Clayton Utz

Party: Biostime International Holdings (Acquirer)

Lawyers: Alexander Schlosser, Niro Ananda, Rory Moriarty

Freshfields Bruckhaus Deringer

Party: Biostime International Holdings (Acquirer)

Lawyers: Daniel French, Simon Weller

Herbert Smith Freehills

Party: Swisse Wellness (Seller)

Lawyer: Raji Azzam

Related deals